Close
Presentations (slides, Video) and Abstract are available to GBCC Sign-up members.
You can access after log-in.
GBCC
Previous Meetings
GBCC Information
GBCC Resources
Previous Meetings
Photo Album
Announcement
What’s NEW
Previous Meetings (GBCC 2015 & 4th IBCS)
※Photographing or reproducing slides, videos of presentations, and abstracts is strictly prohibited without prior permission from the presenter and/or the GBCC.
*Uploaded presentation materials and recording videos of presentation are under the copyright transfer agreement.
Day 1, Apr 23 (Thu) Day 2, Apr 24 (Fri) Day 3, Apr 25 (Sat)
11:10-12:10
  • Plenary Lecture 1
      
  • Venue:  
    Halla Hall
  • Genetic Signature in Selecting Adjuvant Treatment
    Daniel F. Hayes (Internal Medicine, Hematology Oncology, Univ. of Michigan Comprehensive Cancer Center, U.S.A.)Abstract
12:10-13:10
  • Luncheon Symposium 1 (Sponsored by AstraZeneca)
      
  • Venue:  
    Halla Hall
  • Endocrine Therapy in Advanced Breast Cancer
    Young-Hyuck Im (Department of Hematology-oncology, Samsung Medical Center, Korea)Slide ViewAbstract
13:30-14:30
  • Plenary Lecture 2
      
  • Venue:  
    Halla Hall
  • Recent Consensus of Sentinel Lymph Node Biopsy
    Hiram S. Cody III (Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, U.S.A.)Slide ViewAbstract
14:40-15:50
  • Symposium 1: 
    Translational Research 1  
  • Venue:  
    Halla Hall
  • Tumor Microenvironment on Metastasis Research
    Zena Werb (Department of Anatomy, Univ. of California, San Francisco, U.S.A.)Slide ViewAbstract
  • Circulating Tumor Cell
    Min Yu (Stem Cell Biology and Regenerative Medicine, Univ. of Southern California, U.S.A.)Abstract
  • PDX
    Hyeong-Gon Moon (Department of Surgery, Seoul National Univ. Hospital, Korea)Slide ViewAbstract
  • Panel Discussion 1: 
    Breast Cancer Screening  
  • Venue:  
    Lotus Hall
  • Pros
    Haydee Ojeda-Fournier (Department of Radiology, UC San Diego Health System, Moores Cancer Center, U.S.A.)Slide ViewAbstract
  • Cons
    Jae Kwan Jun (National Cancer Control Institute, National Cancer Center, Korea)Slide ViewAbstract
  • Oral Presentation 1
      
  • Venue:  
    Weolla Room
  • [OP1-1] PROGNOSTIC VALUE OF TUMOR-TO-BREAST VOLUME RATIO VS. TUMOR SIZE REVISION OF TNM
    Alisher Kakhkharov (Department of Oncology and Radiology, Tashkent Medical Academy, Uzbekistan)Abstract
  • [OP1-2] DOES INTERNAL MAMMARY NODE IRRADIATION AFFECT TREATMENT OUTCOME IN CLINICAL STAGE II-III BREAST CANCER PATIENTS RECEIVING NEOADJUVANT CHEMOTHERAPY?
    Kyung Hwan Kim (Department of Radiation Oncology, Yonsei Cancer Center, Yonsei Univ. College of Medicine, Korea)Abstract
  • [OP1-3] TAU AND HER2 PREDICT PATHOLOGIC COMPLETE RESPONSE FOR ESTROGEN RECEPTOR-POSITIVE BREAST CANCER
    Kun Wang (Department of Breast Cancer, Guangdong General Hospital, China )Abstract
  • [OP1-4] SURVIVAL OUTCOME OF CONCURRENT GnRH AGONIST PLUS TAMOXIFEN IS COMPARABLE TO THAT OF SEQUENTIAL ADRIAMYCIN AND CYCLOPHOSPHAMIDE CHEMOTHERAPY PLUS TAMOXIFEN IN PREMENOPAUSAL, LYMPH NODE-NEGATIVE, HORMONE-RESPONSIVE, HER2-NEGATIVE, T1-2 BREAST CANCER PATIENTS
    Guiyun Sohn (Division of Breast and Endocrine Surgery, Department of Surgery, ASAN Medical Center, Korea ) Abstract
  • [OP1-5] A PHASE II STUDY OF NEOADJUVANT CHEMOTHERAPY USING COMBINED TAXANE, ANTHRACYCLINE, AND CYCLOPHOSPHAMIDE IN HIGH RISK HER2-NEGATIVE LOCALLY ADVANCED BREAST CANCER
    Joanne Wing Yan Chiu (Department of Medicine, Queen Mary Hospital, Univ. of Hong Kong, Hong Kong)Abstract
  • [OP1-6] PREDICTION OF THE BENEFIT OF RADIATION THERAPY AFTER BREAST-CONSERVING SURGERY IN ELDERLY BREAST CANCER PATIENTS: NOMOGRAM LEADS THE WAY
    Kai Chen (Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen Univ., China )Abstract
  • [OP1-7] EARLY CARDIAC TOXICITY WITH CONCURRENT TRASTUZUMAB AND LEFT-SIDED ADJUVANT RADIOTHERAPY
    Lu Cao (Department of Radiation Oncology, Fudan Univ. Shanghai Cancer Center, China)Abstract
  • [OP1-8] NEOADJUVANT LETROZOLE AND LAPATINIB IN ASIAN POSTMENOPAUSAL WOMEN WITH ESTROGEN RECEPTOR AND HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR-2 POSITIVE BREAST CANCER (NEO-ALL-IN): FIRST EFFICACY AND SAFETY REPORT
    Ji Hyun Park (Department of Oncology, ASAN Medical Center, Korea)Abstract
16:00-17:10
  • Symposium 2: 
    Management Issues after Neoadjuvant Chemotherapy  
  • Venue:  
    Halla Hall
  • Radiation Therapy after NAC (Neoadjuvant Chemotherapy)
    Julia White (Department of Radiation Oncology, The Ohio State Univ., U.S.A.)Slide ViewAbstract
  • Surgical Issues
    Hiram S. Cody III (Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, U.S.A.)Slide ViewAbstract
  • Response Evaluation
    Haydee Ojeda-Fournier (Department of Radiology, UC San Diego Health System, Moores Cancer Center, U.S.A.)Slide ViewAbstract
  • Panel Discussion 2: 
    PMRT in N1  
  • Venue:  
    Lotus Hall
  • Pros
    Jin Hee Kim (Department of Radiation Oncology, Keimyung Univ. Dongsan Medical Center, Korea)Slide ViewAbstract
  • Cons
    Won Park (Department of Radiation Oncology, Samsung Medical Center, Korea)Slide ViewAbstract
  • Education Session 1: 
    Recent Update in Management of Breast Cancer  
  • Venue:  
    Weolla Room
  • Medical Oncology
    Jin-Hee Ahn (Department of Oncology, ASAN Medical Center, Korea)Slide ViewAbstract
  • Surgical Oncology
    Kazuhiko Sato (Department of Breast Oncology, Tokyo West Tokushukai, Japan)Slide ViewAbstract
  • Radiation Oncology
    Yong Bae Kim (Department of Radiation Oncology, Yonsei Univ. Medical Center, Korea)Slide ViewAbstract


Back to Previous Meetings+





Global Breast Cancer Conference Secretariat

Partner I INTERCOM Convention Services, Inc. (Core PCO)

TOP